A synthetic derivative, GnRH [6-D-Phe], stable against enzymatic degradation, self-assembles and forms nanostructures and fibrils upon a pH shift in the presence of different concentrations of Zn 2+ in vitro. Attenuated Total Reflection Fourier Transform Infrared spectroscopy (ATR-FTIR) revealed the existence of higher order assembly of Zn 2+ : GnRH [6-D-Phe]. Nuclear Magnetic Resonance spectroscopy (NMR) indicated a weak interaction between Zn 2+ and GnRH [6-D-Phe]. Atomic Force Microscopy (AFM) showed the existence of GnRH [6-D-Phe] oligomers and fibrils. Molecular Dynamic (MD) simulation of the 10:1 Zn 2+ : GnRH [6-D-Phe] explored the interaction and dimerization processes. In contrast to already existing short peptide fibrils, GnRH [6-D-Phe] nanostructures and fibrils form in a Tris-buffered pH environment in a controlled manner through a temperature reduction and a pH shift. The lyophilized Zn 2+ : GnRH [6-D-Phe] assembly was tested as a platform for the sustained delivery of GnRH [6-D-Phe] and incorporated into two different oil vehicle matrices. The in vitro release was slow and continuous over 14 days and not influenced by the oil matrix.
precipitation was applied in another study with GnRH, tyroliberin (TRH), dalarelin and ACTH for the formation of Zn 2+ -peptide aqueous suspension 17 . Comparable to hGH, LHRH exhibited a similar tendency to form β-sheet rich aggregates with amyloid-like character 15 . In both cases, peptides with the ability to form amyloids were investigated. The amyloid structures are highly organized stable aggregates, which in most cases are associated with neurodegenerative diseases 18 . However, in the studies with hGH and LHRH, the concept of amyloids was applied to prepare complexes capable of slowly releasing the active peptide.
Based on the "amyloid concept" from these studies, we investigated whether a controlled pH shift in the presence of different concentrations of Zn 2+ would lead to self-assembly and formation of nanostructures and fibrils of a synthetic D-Phenylalanine (Phe) form of GnRH peptide in vitro. The use of the synthetic form of GnRH aimed to achieve higher stability against degradation of the assembly 19 (Fig. 1 ).
Results and Discussion
New approach to fibrillize and self-assemble GnRH [6-D-Phe] by Zn 2+ and controlled pH shift.
In the current study we applied two techniques for fibrillizing GnRH [6-D-Phe] and compared them to each other in order to select the most suitable one. The percentage of free GnRH [6-D-Phe] was analyzed by Reversed-Phase Chromatography (RP-HPLC).
The first technique was the method of choice used in earlier studies of precipitating LHRH, rHir, ACTH, TRH etc. and involved increasing the pH of the peptide solution containing Zn 2+ from 7.2 to 8.2 by the addition of NaOH 5, 16, 17, 20 . The GnRH [6-D-Phe] was complexed at 2.5 mg/mL from 5 mg/mL bulk concentration. Below pH 7.8 the percentage of precipitated GnRH [6-D-Phe] remained low at all Zn 2+ : GnRH [6-D-Phe] molar ratios and no correlation between molar ratio and pH could be obtained. Above pH 7.8, we observed an increase and a maximum of precipitated GnRH [6-D-Phe] of 95.9 ± 0.1% at a 10:1 Zn 2+ : GnRH [6-D-Phe] molar ratio ( Fig. 2a ; Supplementary Data and Information Table 1 ). The high percentage of precipitated peptide might be due to the interaction of the histidine (His) side chain with Zn 2+ through its imidazole group. One major drawback of the technique is the unsatisfactory accuracy using the pH-adjustment with NaOH solution due to lack of buffer capacity at the pH value of interest. Thus upon addition of NaOH extremely unstable and high local pH values may result. This can lead on the one hand to the coinciding precipitation of Zn (OH) 2 from a mixture of complexed, free peptide and unbound Zn 2+ and on the other to epimerization at the serine (Ser) of GnRH [6-D-Phe], preceding a Ser hydroxyl group triggered peptide bond hydrolysis 21 .
The second technique was based on a recent study of Valery et al., which showed that a change of pH value and thus deprotonation of the His residue in the GnRH agonist, TRH, could trigger a self-assembly of the peptide into nanotubes 22 . This pH dependent switch can be applied in the bottom-up development of pH-responsive nanomaterials as well as for the in vitro induced conformational change and fibrillation of GnRH [6-D-Phe]. In our study, this was achieved through a temperature controlled pH-shift between 7.2 and 8.2 with a Tris-buffered system, as an alternative to NaOH 23 .
The percentage of precipitated peptide reached 99.2 ± 0.2% at a 10:1 Zn 2+ : GnRH [6-D-Phe] ratio in 0.05 M Tris buffer pH 7.8 after temperature reduction from 25 °C to 5 °C, over 24 h. In contrast, the precipitation efficiency in a 0.05 M Tris buffer pH 7.2 reached only 36.2 ± 0.1% (Fig. 2b ). This could be explained by the measured-temperature-induced pH increase of the Tris-buffered system with 0.03 pH units per 1 °C 24 . Cooling the Zn 2+ : GnRH [6-D-Phe] in Tris buffer (pH 7.8) from 25 °C to 5 °C promoted a pH increase from pH 7.3 to pH 7.9. At this pH the His-side chain is in a deprotonated state and can form hydrogen bonds or enhance the peptide interaction with Zn 2+ and the formation of an assembly. In contrast the solution of Zn 2+ : GnRH [6-D-Phe] in Tris buffer with pH 7.2 reached pH 7.3 at 5 °C (Supplementary Data and Information Table 2 ). 
Existence of higher-order assembly of GnRH [6-D-Phe].
In order to study the conformational changes and secondary structures, resulting upon adding different molar concentrations of Zn 2+ to GnRH [6-D-Phe], we used Attenuated Total Reflection Fourier Transform Infrared spectroscopy (ATR-FTIR). The bands at 1416 cm −1 and 1434-1454 cm −1 indicated an increase in the C-H bending and -C = O stretching vibration, respectively [25] [26] [27] (Fig. 3a ). Absorbance spectra analysis in the amide II range (1500-1600 cm −1 ) yielded two major peaks at ~1520 cm −1 and 1560 cm −1 . The peak at 1560 cm −1 can be assigned to the N-H bend in plane and stretch. The peak at 1520 cm −1 has been associated in earlier studies with vibrations of heterocyclic compounds, e.g. furan ring, phenyl ring, imidazole ring and can be attributed to the stretching vibration of the -C=N bond in the imidazole heterocycle of the His side chain [28] [29] [30] (Fig. 3a) . The amide I region (1600-1700 cm −1 ) presented one major band at 1650 cm −1 as an indicator of an alpha-helical structure. The characteristic beta-sheet regions of 1610-1630 cm −1 and 1680-1700 cm −1 were visibly overlapped from the major alpha-helical peak. A deconvolution of the absorbance spectra could unveil a beta-sheet peak in the 1604-1617 cm −1 range (Supplementary Data and Information Fig. 2 ). With increasing Zn 2+ molar concentrations, most stunning appears to be the change in the percentage of beta-sheet and carbonyl stretching area. The observed changes are good indicators of the initiation of oligomer formation at 4:1 and the maximum stretching of the carbonyl group at 10:1 Zn 2+ : GnRH [6-D-Phe] molar ratios ( Fig. 3a , Table 1 ). With higher Zn 2+ concentrations the beta-sheet peak disappeared and an increase of the carbonyl stretching due to the formation of ZnO/Zn (OH) 2 resulted. Its strong peak at 1560 cm −1 coincides with the peptide amide II region. Analysis of the second-derivative amide I region showed bands at ~1611 cm −1 and at ~1690 cm −1 , typical for oligomers in solution [31] [32] [33] [34] [35] [36] (Fig. 3b ). This supports the hypothesis that the oligomeric structure of GnRH [6-D-Phe] forms with increasing molar concentration of Zn 2+ .
Binding of Zn 2+ to GnRH [6-D-Phe].
The LHRH interactions with Zn 2+ , Ni 2+ and Cu 2+ were studied in the 1980s 17, 20 . The results of the 1 H-NMR spectroscopy favored a view that the coordination between Zn 2+ and LHRH takes place at the carbonyl oxygen of the His-Trp peptide bond 20 . In addition, the imidazole of the His residue coordinates to the Zn 2+ ligand. This coordination to Zn 2+ happens in a fast proton exchange. The changes of the chemical shift in the aromatic part of the 1 H-NMR in correlation to the added molar concentration of Zn 2+ can be traced back to two distinct occurrences. The first one involves the already mentioned His and Trp residue interaction with Zn 2+ (Supplementary Data and Information Fig. 1 ). The second one can be due to a stronger peptide-peptide interaction 37,38 . Using the observed change in the chemical shift (Δδ), we fitted the data to a hyperbolic function with the following equation: Fig. 3 ). The assembly process appeared to be dynamic and going through different stages: immediately after preparation large circular aggregates formed ( Fig. 5a ), which resulted after 48 h in 5 nm nanostructures ( Fig. 5b ). The smaller size oligomers might be due to solvation of peptide chains from the preliminary formed large aggregate back into solution. In dry state, Zn 2+ : GnRH [6-D-Phe] small fibrils with a diameter of up to 10 nm were observed ( Fig. 5c,d) .
The effect of increasing Zn 2+ ion concentration on GnRH [6-D-Phe] fibrillization was further studied with Thioflavin T (ThT) assay. ThT is a benzothiazole dye used to visualize and quantify misfolded protein fibrils or amyloid both in vitro and in vivo 39 . The assay could show the formation of secondary structures with increasing Zn 2+ concentration. Above a 10:1 Zn 2+ : GnRH [6-D-Phe] ratio, the obtained fluorescence values decreased. Pure GnRH [6-D-Phe] and aggregated Aβ42 were included and served as negative and positive control, respectively ( Table 2) . Fig. 4 ). These interactions could further confirm the observed weak coordination of Zn 2+ to GnRH [6-D-Phe] in the 1 H-NMR spectra 40, 41 . In the first dimerization event, the Arg8 residue of peptide 1 was engulfed by the second peptide. The dimer's interface consists of Leu7, Arg8 and Pro9 of peptide 1 and pGlu1, Ser4, Pro9, Gly-NH 2 10 of peptide 2 (Fig. 6a ). The second and third dimerization events present a flatter interface, which is composed of residues pGlu1, His2 Tyr5 D-Phe6 Pro9 of peptide 1 and Trp3 Ser4 Tyr5 of peptide 2 (Fig. 6b ). During the first dimerization event there was a pronounced conformational change of peptide 1, reflected from the RMSD values ( Fig. 6c,d) . A cluster analysis showed that the dimer formed in the first dimerization event (at around 10000 frames) is the most prominent species in the course of the simulation. MD simulations showed that the dimer formation is furthermore driven by hydrogen bond formation between the peptide residues (Supplementary Data and Information Fig. 5 ). (Fig. 8) . In contrast, the preformed complex formulations in OV1 and OV2 showed slow and continuous in vitro release profiles over 14 days with a minor burst effect. The release from the reference formulation based on pure GnRH [6-D-Phe] in castor oil: MCT 50:50% (w/w) was fast and almost complete within 24 h. In contrast the release was more sustained over 4 days from MCT +3% (w/w) AlSt +1% (w/w) PL 90 H +5% (w/w) KP ELP.
Self-assembled Zn
In order to determine the release kinetics from the Zn 2+ : GnRH [6-D-Phe] formulations, the data was fitted to first-order, Higuchi, zero-order and Korsemeyer-Peppas models 42 . The formulations clearly did not follow zero order release kinetics (Fig. 9 ). The model that best fitted the release data was evaluated by correlation coefficient (Table 3 ). The release profile of the preformed complex formulation in OV1 could be best explained by Higuchi model, as the plot showed linearity with R 2 value of 0.9416. The Korsmeyer-Peppas plots of all formulations showed fair linearity (R 2 values between 0.95-0.97) with a considerably high slope value (n). This indicated a coupling of diffusion and erosion mechanisms or so called anomalous diffusion 43 .
Compared to the reference formulations without Zn 2+ , the release profiles of the complex and in situ complex formulations were not influenced by the oil matrix. Thus the interaction of Zn 2+ with GnRH [6-D-Phe] in a preformed lyophilized complex could accomplish a superior controlled release of GnRH [6-D-Phe] with minor burst effect. It represents a simple and scalable formulation approach.
Conclusion
As illustrated above a short synthetic decapeptide, GnRH 7.8-8.2 environment in a controlled manner through temperature reduction and a pH shift. The in vitro release of the GnRH [6-D-Phe] peptide from the freeze-dried assembly was sustained and continuous over 14 days and can be viewed as a promising platform for the controlled delivery of peptides. Recent articles have highlighted the numerous fields of application of similar self-assembled peptide -based nanostructures [44] [45] [46] . The further investigation of the GnRH [6-D-Phe]: Zn 2+ self-assembling/oligomerization process is necessary as to evaluate to what extent it can find application in other research fields.
Materials and Methods
Gonadorelin [6-D-Phe] acetate peptide (pE1-H2-W3-S4-Y5-(D) F6-L7-R8-P9-G10-NH2) or(pGlu-His-Trp-Ser-Tyr-D-Phe-Leu-Arg-Pro-Gly-NH2) was provided by BFC Biopept-Feinchemie aslyophilized powder and acetate salt (purity 99.76%, water content 6.73% and acetate peptide ratio (MW/MW) 1.8). Table 1 ). Table 2 ). solution in a 0.05 M Tris buffer (pH 7.8) were combined. Aliquots of 30 µl of each prepared solution were loaded and the spectra were recorded with a Tensor 27 FTIR spectrometer (Bruker Optics, Ettlingen, Germany) using a Bio-ATR unit at 20 °C. Corresponding blank spectra were subtracted. Spectra were recorded at 4 cm −1 resolution and the second derivative spectrum was generated (OPUS, Bruker Optics, Ettlingen, Germany).The spectra data analysis and Fourier Self-Deconvolution (FSD) was performed with Origin 2018 software. FSD was performed using bandwidth of 10 cm −1 and noise suppression factor of 0.3. The structure content of the deconvoluted peaks was determined using Gaussian band shapes by an iterative curve fitting. Atomic force microscopy (tapping in Air). The 10:1 Zn 2+ : GnRH [6-D-Phe] (20 ng/µL; 20 µL volume) was deposed onto poly-L-lysine coated mica for 2 min, followed by gentle rinsing with water and dried in a N 2 -gas stream. Coating the mica with (+) charged poly-L-lysine repulsed the (+) charged arginine peptide residues of chains not involved in the dimerization process, allowing better imaging. AFM imaging was performed on a Multimode AFM, equipped with a Nanoscope III controller and a type E scanner. Images were recorded on dried samples, under ambient conditions, and using Silicon cantilevers (Olympus; AC160TS; resonance frequency ≈300 kHz). Typical scans were recorded at 1-3 Hz line frequency, with optimized feedback parameters and at 512 × 512 pixels. For image processing and analysis, Scanning Probe Image Processor (v6.4; Image Metrology) was employed. Image processing involved background correction using global fitting with a third-order polynomial and line-by-line correction through the histogram alignment routine. buffer solution) . The AFM images were performed using the AFM NanoWizard ® 4 from JPK Instruments with SPM software and an integrated Axiovert 200 inverted microscope from Zeiss. As cantilever the qp-BioAC CB3 (Nanosenors; resonance frequency ≈30 kHz) was used. A mica-chip was glued on a microscope slide and 20 µl of the 10:1 Zn 2+ : GnRH [6-D-Phe] was added. After 5 min incubation time, the mica-substrate was washed with Tris buffer. The imaging was performed in 1 ml Tris buffer and with the tapping mode (QI ™ Advanced Imaging). The following values have been set: Z-length 50-70 nm; duration 2 ms and pixel size 256 × 256. All images were processed and optimized with Data Processing Software from JPK. The processing involved removing incorrect lines, replacing outlier pixel values with the median value of neighbouring pixels and line-by-line correction with a first-order polynomial fit. A histogram is calculated for each line and only the data between the lower and upper limits is used for fitting the polynomial. MD simulations. Molecular dynamic simulations were performed using the Amber 16 suite 47 . Non-standard residue files were generated using antechamber and the peptide structure was generated with t-leap. Two identical GnRH [6-D-Phe] molecules and 20 zinc ions were placed at random coordinates in a TIP3P water box using 10 Å of padding. Energy minimization was performed with pmemd. MPI with the steepest descent method for 5000 cycles and with the conjugate gradient method at constant volume for the remaining 45000 cycles. The system was then heated from 0 to 300 K and equilibrated for 200 ps with pmemd.cuda. A Langevin thermostat with a collision frequency set to 5 ps −1 was used. Pressure was kept constant using isotropic position scaling and a Monte Carlo barostat. The SHAKE algorithm was turned on. After equilibration, a 500 ns production run was performed with the same thermostat and barostat settings as during equilibration. VdW and electrostatic interaction energies were calculated using the LIE method as implemented in cpptraj and plotted with matplotlib 40, 41, 48 . . HEPES was selected as medium instead of PBS buffer, since phosphate can precipitate the zinc salt from the complex. 2 mL oil depot suspension was weighted into a falcon tube, 4 mL DCM and 6 mL HEPES (pH 7.4) were added. The tube was shaken or vortexed at room temperature (25 °C) and put into an incubated shaker 3031 (GFL, Germany) at 39 °C and 60 rpm for 48 h. The RP-HPLC analysis was performed at 220 nm. A second extraction method was applied: 2 ml of each formulation were pipetted into 6 ml HEPES (pH 7.4). The falcon tubes were placed in an incubated shaker 3031 (GFL, Germany) at 39 °C and 60 rpm for 48 h. The tubes were then centrifuged for 60 minutes at 4000 rpm and 5 °C. 1 ml of the lower aqueous phase was used for RP-HPLC at 220 nm. The second extraction with HEPES (pH 7.4) delivered results of nearly 100% and indicated high extraction efficiency.
Formation of the Zn 2+ : GnRH [6-D-Phe] assembly in Tris buffer. Equal amounts of 4 mM GnRH
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In vitro release study. The in vitro release study was conducted using VISKING ® dialysis tubing, MWCO 12-14 kD, RC, 28 mm (SERVA, Germany). The tubes were filled with 1.5 mL formulation. The release medium was 20 mL HEPES (pH 7.4). HEPES was selected as release medium instead of PBS buffer, since phosphate can precipitate the zinc salt from the complex. The in vitro evaluation was performed in duplicates and in an incubated shaker 3031 (GFL, Germany) at 39 °C and 60 rpm. buffer (pH 7.4). After 48 hours of an equilibration of the peptide between the two phases the emulsion was centrifuged for 60 minutes at 4000 rpm and 5 °C. The quantity of the peptide in the lower aqueous phase was analysed by RP-HPLC at 220 nm.
Determination of the GnRH [6-D-Phe] (RP-HPLC).
The GnRH [6-D-Phe] content in the formed precipitate/fibrils was analysed by RP-HPLC after dissolution in 0.1% acetic acid, using a LUNA C8 (4.6 × 250 mm; size = 5 µm; Phenomenex, USA) column, with a C8 pre-column (4 × 3 mm; size = 5 µm) at an HPLC Agilent 1100/1200 series (Agilent Technologies, USA) (mobile phase A (water +1 mL/L Trifluoroacetic acid (TFA) (v/v)) and mobile phase B (800 g Acetonitrile +200 g water +1.2 mL TFA), 1.1 mL/min flow, column temperature 40 °C, and autosampler temperature 2-8 °C. The Retention Time (RT) of GnRH [6-D-Phe] was 8.5 ± 1.5 minutes with UV detection at 220 nm.
